Physicochemical characterization and toxicity of decursin and their derivatives from Angelica gigas

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 7, 2012, Pages 1084-1090

  Mahat, Bimit ^a   Chae, Jung Woo ^a   Baek, In Hwan ^d   Song, Gyu Yong ^a   Song, Jin Sook ^b   Cho, Seong Kwon ^c   Kwon, Kwang Il ^a  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c Samnam Pharmaceuticals   (South Korea)

^d Yuhan Research Institute   (South Korea)

Author keywords

Angelica gigas; Diketone decursin; Institute of Cancer Research mice; Physicochemical; Toxicology

Indexed keywords

CYTOTOXIC AGENT; DECURSIN; DECURSINOL ANGELATE; DIKETONE DECURSIN; EPOXIDE DECURSIN; ETHER DECURSIN; OXIM DECURSIN; UNCLASSIFIED DRUG;

AMES TEST; ANGELICA; ANGELICA GIGAS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL MEMBRANE; BACTERIAL CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG PENETRATION; DRUG SOLUBILITY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PKA; SALMONELLA TYPHI; SINGLE DRUG DOSE; TOXICITY TESTING;

ANGELICA; ANIMALS; BENZOPYRANS; BUTYRATES; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED ICR; MUTAGENICITY TESTS; NIH 3T3 CELLS; PERMEABILITY; PLANT EXTRACTS; SALMONELLA TYPHIMURIUM;

EID: 84863552955     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00046     Document Type: Article

References (34)

1. Caldwell GW. Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens. Curr. Opin. Drug Discov. Devel., 3, 30-41 (2000).
2. Chen XQ, Antman MD, Gesenberg C, Gudmundsson OS. Discovery pharmaceutics - challenges and opportunities. AAPS J., 8, E402-E408 (2006).
3. Li AP. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov. Today, 6, 357-366 (2001).
4. Alsenz J, Kansy M. High throughput solubility measurement in drug discovery and development. Adv. Drug Deliv. Rev., 59, 546-567 (2007).
5. Hecht SS. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst., 91, 1194-1210 (1999).
6. Suja SR, Latha PG, Pushpangadan P, Rajasekharan S. Evaluation of hepatoprotective effects of Helminthostachys zeylanica (L.) HOOK against carbon tetrachloride-induced liver damage in Wistar rats. J. Ethnopharmacol., 92, 61-66 (2004).
7. Lewis DF, Ioannides C, Parke DV. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U.S.A. NCI/NTP. Mutat. Res., 291, 61-77 (1993).
8. Walum E. Acute oral toxicity. Environ. Health Perspect., 106 (Suppl. 2), 497-503 (1998).
9. Llinàs A, Glen RC, Goodman JM. Solubility challenge: can you predict solubilities of 32 molecules using a database of 100 reliable measurements? J. Chem. Inf. Model., 48, 1289-1303 (2008).
10. Bevan CD, Lloyd RS. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal. Chem., 72, 1781-1787 (2000).
11. Gardner CR, Walsh CT, Almarsson O. Drugs as materials: valuing physical form in drug discovery. Nat. Rev. Drug Discov., 3, 926-934 (2004).
12. Avdeef A, Testa B. Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques. Cell. Mol. Life Sci., 59, 1681-1689 (2002).
13. Cyprotex discovery. Parallel artificial membrane permeability assay (PAMPA).:〈http://www.cyprotex.com/cloescreen/in-vitro-permeability/ pampa〉, cited December, 2011.
14. Kim KM, Kim MJ, Kang JS. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas NAKAI. J. Microbiol. Biotechnol., 19, 1569-1572 (2009).
15. Baek IH, Chae JW, Song GY, Kwon KI. LC-MS/MS Assay validation for a new immune modulator, JHL45, and its major metabolite in plasma: Application to pharmacokinetic studies in rats. Bull. Korean Chem. Soc., 30, 2631-2636 (2009).
16. Song JS, Chae JW, Lee KR, Lee BH, Choi EJ, Ahn SH, Kwon KI, Bae MA. Pharmacokinetic characterization of decursinol derived from Angelica gigas NAKAI in rats. Xenobiotica, 41, 895-902 (2011).
17. Green C, Mckee S, Saunders K. A fully automated kinetic solubility screen in 384 well plate format using nephelometry.: 〈http://www.bmglabtech.com/ db-assets/applications/downloads/AN117-solubility-screening-nephelometry- NEPHELOstar.pdf〉, cited October, 2004.
18. adetermination by capillary electrophoresis. Chem. Biodivers., 6, 1822-1827 (2009).
19. Fuguet E, Ràfols C, Bosch E, Rosés M. Fast high-throughput method for the determination of acidity constants by capillary electrophoresis: I. Monoprotic weak acids and bases. J. Chromatogr. A, 1216, 3646-3651 (2009).
20. a determination by capillary electrophoresis. Electrophoresis, 29, 2841-2851 (2008).
21. Völgyi G, Baka E, Box KJ, Comer JE, Takács-Novák K. Study of pH-dependent solubility of organic bases. Revisit of Henderson - Hasselbalch relationship. Anal. Chim. Acta, 673, 40-46 (2010).
22. Krämer SD, Gautier JC, Saudemon P. Considerations on the potentiometric log P determination. Pharm. Res., 15, 1310-1313 (1998).
23. Avdeef A. pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances. J. Pharm. Sci., 82, 183-190 (1993).
24. Allen RI, Box KJ, Comer JE, Peake C, Tam KY. Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs. J. Pharm. Biomed. Anal., 17, 699-712 (1998).
25. Hwang KK, Martin NE, Jiang L, Zhu C. Permeation prediction of M100240 using the parallel artificial membrane permeability assay. J. Pharm. Pharm. Sci., 6, 315-320 (2003).
26. Pucaj K, Rasmussen H, Møller M, Preston T. Safety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7. Toxicol. Mech. Methods, 21, 520-532 (2011).
27. Gomes-Carneiro MR, Viana ME, Felzenszwalb I, Paumgartten FJ. Evaluation of beta-myrcene, alpha-terpinene and (+)- and (-)-alpha-pinene in the Salmonella/microsome assay. Food Chem. Toxicol., 43, 247-252 (2005).
28. Ames BN, Mccann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res., 31, 347-364 (1975).
29. Hong CE, Lyu SY. Genotoxicity detection of five medicinal plants in Nigeria. J. Toxicol. Sci., 36, 87-93 (2011).
30. Cayman chemical company. WS-8 cell proliferation assay kit.: 〈http://www.caymanchem.com/pdfs/10010199.pdf〉, cited November, 2010.
31. Mohd-Fuat AR, Kofi EA, Allan GG. Mutagenic and cytotoxic properties of three herbal plants from Southeast Asia. Trop. Biomed., 24, 49-59 (2007).
32. a measurements and their use. :〈http://www.raell.demon.co.uk/chem/logp/logppka.htm#phscale〉, cited March, 2006.
33. Teufel R, Friedrich T, Fuchs G. An oxygenase that forms and deoxygenates toxic epoxide. Nature, 483, 359-362 (2012).
34. Oesch F, Herrero ME, Hengstler JG, Lohmann M, Arand M. Metabolic detoxification: implications for thresholds. Toxicol. Pathol., 28, 382-387 (2000).